Education
About Us
Working with TipRanks
Follow Us
Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF)
:FF
RESEARCH TOOLSreports
FF Stock Chart & Stats
Day’s Range― - ―
52-Week Range€6.46 - €9.62
Previous CloseN/A
Volume1.45K
Average Volume (3M)10.94K
Market Cap
€180.39M
Enterprise Value€221.56M
Total Cash (Recent Filing)€19.21M
Total Debt (Recent Filing)€54.53M
Price to Earnings (P/E)19.3
Beta0.15
Next Earnings
Aug 05, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 28, 2025Dividend Yield1.63%
Share Statistics
EPS (TTM)0.17
Shares Outstanding22,060,125
10 Day Avg. Volume5,058
30 Day Avg. Volume10,943
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.39
Price to Sales (P/S)0.00
P/FCF Ratio16.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€11.70Price Target Upside58.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Fine Foods & Pharmaceuticals N.T.M. SpA News
Bulls Say, Bears Say
Bulls Say
Earnings1Q25 was the best ever in terms of EBITDA and margin, achieved fully organically and through traditional actions.
Financial PerformanceRecord profitability was boosted by the Cosmetics repositioning, contributing to improved margins and profitability.
Bears Say
GrowthThe Nutra business unit is expected to have slower growth assumptions, leading to a slight reduction in group revenue.
RevenueA relatively challenging YoY comparison and different order phasing led to a drop in group revenues.
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
FF FAQ
What was Fine Foods & Pharmaceuticals N.T.M. SpA’s price range in the past 12 months?
Fine Foods & Pharmaceuticals N.T.M. SpA lowest stock price was €6.46 and its highest was €9.62 in the past 12 months.
What is Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap?
Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap is €180.39M.
When is Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date?
Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date is Aug 05, 2025 which is in 59 days.
How were Fine Foods & Pharmaceuticals N.T.M. SpA’s earnings last quarter?
Fine Foods & Pharmaceuticals N.T.M. SpA released its earnings results on May 08, 2025. The company reported €0.165 earnings per share for the quarter, beating the consensus estimate of N/A by €0.165.
Is Fine Foods & Pharmaceuticals N.T.M. SpA overvalued?
According to Wall Street analysts Fine Foods & Pharmaceuticals N.T.M. SpA’s price is currently Undervalued.
Does Fine Foods & Pharmaceuticals N.T.M. SpA pay dividends?
Fine Foods & Pharmaceuticals N.T.M. SpA pays a Annually dividend of €0.14 which represents an annual dividend yield of 1.63%. See more information on Fine Foods & Pharmaceuticals N.T.M. SpA dividends here
What is Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate?
Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fine Foods & Pharmaceuticals N.T.M. SpA have?
Fine Foods & Pharmaceuticals N.T.M. SpA has 22,060,125 shares outstanding.
What happened to Fine Foods & Pharmaceuticals N.T.M. SpA’s price movement after its last earnings report?
Fine Foods & Pharmaceuticals N.T.M. SpA reported an EPS of €0.165 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.111%.
Which hedge fund is a major shareholder of Fine Foods & Pharmaceuticals N.T.M. SpA?
Currently, no hedge funds are holding shares in IT:FF
Company Description
Fine Foods & Pharmaceuticals N.T.M. SpA
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. It offers pharmaceutical products, including powders and granules, capsules, tablets, film-coated tablets, effervescent granules, and hard gelatine capsules. The company also provides nutraceutical products comprising soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, fast melting/sublingual tablets, film-coated tablets, and hard gelatin capsules for various therapeutic areas, such as probiotics, multivitamins and minerals, immune systems, sleep and relax, gastrointestinal system, circulatory system, osteoarticular system, urinary system, women health, beauty, healthy ageing, and mental wellbeing. In addition, the company manufactures and trades in cosmetics products consisting of hair care, skin care, liquid detergents for personal hygiene, skin care emulsions, oral hygiene, deodorants, alcohol-based perfumery, bath and shower gel, shampoo and conditioners, shaping waxes, mouthwash and breath products, creams, gel and toothpaste, roll-on, stick and vapo spray deodrants, intimate cleansers, emulsions and microemulsions, gels, and liquid soaps; medical surgical aids and medical devices; antiseptics for undamaged skin, hand gel, pre-injection, hydroalcoholic surfaces, and iodine; and orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. The company was founded in 1984 and is headquartered in Verdellino, Italy.
FF Stock 12 Month Forecast
Average Price Target
€11.70
▲(58.54%Upside)